UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 7, 2026
Accession Number:
0001493152-26-000155
Submission Type:
POS AM
CIK:
0001716166
Company Name:
Vivos Therapeutics, Inc.
File Number:
333-278564